Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting

Control of chemotherapy-induced nausea and vomiting (CINV) is a crucial factor in ensuring that patients undergoing cancer chemotherapy can get the full benefit of therapy. Current antiemetic guidelines recommend that the neurokinin-1 receptor (NK-1R) antagonist aprepitant should be used as part of...

Descripción completa

Detalles Bibliográficos
Autores principales: Celio, Luigi, Ricchini, Francesca, De Braud, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653760/
https://www.ncbi.nlm.nih.gov/pubmed/23687442
http://dx.doi.org/10.2147/PPA.S31288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653760/
https://www.ncbi.nlm.nih.gov/pubmed/23687442
http://dx.doi.org/10.2147/PPA.S31288

Ejemplares similares